Previous studies have investigated the correlations between CDK7 RNA expression and relapse-free survival (RFS) in breast cancer using a microarray database of 3,951 breast cancer patients and found that high expression levels of CDK7 are closely associated with worse RFS in all breast cancer subtypes (20). The gene discussed is CDK7; the disease is breast carcinoma.